 Livongo Health NASDAQ: LVGO shares are trading higher on Monday after Canaccord Genuity maintained its Buy rating on the stock and raised its price target from 110 to 139 per share.Livongo Health provides a data science and technology-enabled platform for the detection of diabetes. Its additional solutions include Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength.The companys clients comprise of employers, health plans, government entities, and labor unions. Its operations are primarily located in the U.S.Livongo Health shares were trading up 5.24 at 124.54 at the time of publication on Monday. The stock has a 52-week high of 150 and a 52-week low of 15.12.Related Links:Livongo Health Shares Open Well Above IPO PriceLivongo Health IPO: What You Need To KnowLatest Ratings for LVGO DateFirmActionFromTo Aug 2020Canaccord GenuityMaintainsBuy Aug 2020CitigroupMaintainsBuy Aug 2020BenchmarkDowngradesBuyHold View More Analyst Ratings for LVGO View the Latest Analyst RatingsSee more from Benzinga Teladoc, Livongo Health Merger Valued At .5B Why Livongo Healths Stock Is Trading Higher Today Why Livongo Healths Stock Is Trading Higher TodayC 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 